Observation on clinical effects of acupoint thread-embedding method for non-alcoholic fatty liver disease
10.1007/s11726-016-0922-6
- VernacularTitle:穴位埋线治疗非酒精性脂肪性肝病临床疗效观察
- Author:
Zhen HUANG
;
Shuanglin SONG
;
Keping TAN
;
Jiamei CHU
;
Xiaoying CHU
;
Youhua ZENG
- Publication Type:Journal Article
- Keywords:
Acupoint Therapy;
Embedding Therapy;
Liver-qi Stagnation and Spleen Deficiency;
Non-alcoholic Fatty Liver Disease;
Syndrome Differentiation Treatment
- From:
Journal of Acupuncture and Tuina Science
2016;14(3):186-191
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the clinical effects of acupoint thread-embedding method for non-alcoholic fatty liver disease (NAFLD) in pattern of liver qi stagnation and spleen deficiency.
Methods: A total of180 cases in conformity with the diagnostic criteria of NAFLD in pattern of liver qi stagnation and spleen deficiency were randomly divided into a treatment group and a control group, 90 cases in each group, and finally 88 cases in the treatment group and 90 cases in the control group were recruited for statistics. The treatment group was managed by acupoint thread-embedding method, and the control group was treated by oral administration of Polyene Phosphatidylcholine capsules. Both groups were treated for 6 months. Before and after the treatment, liver enzymology, blood fat test, abdominal B ultrasonic examination, and assessment of clinical effects were respectively processed.
Results:After treatment, alanine transaminase (ALT), aspartate transaminase (AST), total cholesterol (TC), and triglyceride (TG) decreased in the treatment group, and were significantly different from those in the control group after treatment (allP<0.05). There was no statistically significant inter-group difference in the degree of fatty liver (by B ultrasound examination) before treatment (P>0.05). After treatment, the improvement degree of fatty liver in the treatment group was more significant than that in the control group (P<0.05). The total effective rates were 89.8% in the treatment group and 76.7% in the control group, with a statistically significant difference between the two groups (P<0.05).
Conclusion:The acupoint thread-embedding method can reduce the levels of ALT, AST, TC and TG in NAFLD patients, and can improve the pathologic degree of fatty liver and its clinical effects are remarkably better than that of oral medications.
